Is the price fair?
What PTCT's price assumes
PTC Therapeutics, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is read against sales instead: 6.80× revenue.
6.80
Price / sales · no P/E: the last twelve months did not end in a profit
Details›
- Market capitalisation
- $6.55B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.